A UK national audit of hereditary and acquired angioedema

Clinical and Experimental Immunology

Volumn 175, Issue 1, 2014, Pages 59-67

  Jolles, S ^a   Williams, P ^a   Carne, E ^a   Mian, H ^a   Huissoon, A ^b   Wong, G ^b   Hackett, S ^b   Lortan, J ^c   Platts, V ^c   Longhurst, H ^d   Grigoriadou, S ^d   Dempster, J ^d   Deacock, S ^e   Khan, S ^e   Darroch, J ^f   Simon, C ^g   Thomas, M ^h   Pavaladurai, V ⁱ   Alachkar, H ^j   Herwadkar, A ^j   Abinun, M ^k   Arkwright, P ^l   Tarzi, M ⁿ   Helbert, M ^m   Bangs, C ^m   Pastacaldi, C ^o   Phillips, C ^p   Bennett, H ^p   El Shanawany, T ^a   more..

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e FRIMLEY PARK HOSPITAL   (United Kingdom)

^f ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

ⁱ LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^j SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^k Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m MANCHESTER ROYAL INFIRMARY   (United Kingdom)

ⁿ UNIVERSITY OF SUSSEX   (United Kingdom)

^o SINGLETON HOSPITAL   (United Kingdom)

^p SWANSEA UNIVERSITY   (United Kingdom)

more..

Author keywords

Acquired angioedema; C1 esterase inhibitor, complement; Hereditary angioedema; Primary immunodeficiency; Secondary immunodeficiency; SERPING1

Indexed keywords

ANDROGEN; ANTINUCLEAR ANTIBODY; BLOOD CLOTTING FACTOR 12; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DANAZOL; GLUTAMATE DECARBOXYLASE ANTIBODY; ICATIBANT; NEUTROPHIL CYTOPLASMIC ANTIBODY; THYROID PEROXIDASE ANTIBODY; TRANEXAMIC ACID;

ABDOMINAL SWELLING; ACQUIRED ANGIOEDEMA; ADULT; ANDROGEN THERAPY; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CLINICAL PRACTICE; DELAYED DIAGNOSIS; DISEASE SEVERITY; EMPLOYMENT; FAMILY HISTORY; FEMALE; GENE MUTATION; HEALTH CARE ORGANIZATION; HUMAN; LETHALITY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL DOCUMENTATION; MORTALITY; PATIENT CARE; PERIPHERAL SWELLING; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; UNITED KINGDOM;

ACQUIRED ANGIOEDEMA; C1 ESTERASE INHIBITOR, COMPLEMENT; HEREDITARY ANGIOEDEMA; PRIMARY IMMUNODEFICIENCY; SECONDARY IMMUNODEFICIENCY; SERPING1;

ADULT; ANGIOEDEMAS, HEREDITARY; COST OF ILLNESS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; QUALITY OF LIFE; TIME FACTORS;

EID: 84888864383     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12159     Document Type: Article

References (25)

1. Rosen FS, Pensky J, Donaldson V, Charache P. Hereditary angioneurotic edema: two genetic variants. Science 1965; 148:957-958.
2. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356:213-217.
3. Zuraw BL, Bork K, E Binkley K etal. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc 2012.
4. Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol 2010; 6:14.
5. Cicardi M, Zanichelli A. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema. Curr Mol Med 2010; 10:354-360.
6. Bygum A. Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol 2009; 161:1153-1158.
7. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, Lopez-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 2005; 94:498-503.
8. Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 2012; 130:692-697.
9. Bossi F, Fischetti F, Regoli D etal. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol 2009; 124:1303-10 e4.
10. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693-1697.
11. Nussberger J, Cugno M, Cicardi M, Agostoni A. Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol 1999; 104:1321-1322.
12. Kaplan AP, Joseph K. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol 2010; 104:193-204.
13. Bowen T, Cicardi M, Farkas H etal. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6:24.
14. Cicardi M, Bork K, Caballero T etal. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 2012; 67:147-157.
15. Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet 2012; 379:474-481.
16. Zuraw BL, Busse PJ, White M etal. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 2010; 363:513-522.
17. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Balt) 1992; 71:206-215.
18. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976; 84:580-593.
19. Caballero T, Farkas H, Bouillet L etal. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol 2012; 129:308-320.
20. Craig T, Pursun EA, Bork K etal. WAO guideline for the management of hereditary angioedema. World Allergy Organ J 2012; 5:182-199.
21. Gompels MM, Lock RJ, Abinun M etal. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139:379-394.
22. Weller K, Groffik A, Magerl M etal. Development and construct validation of the angioedema quality of life questionnaire. Allergy 2012; 67:1289-1298.
23. Farkas H, Varga L, Szeplaki G, Visy B, Harmat G, Bowen T. Management of hereditary angioedema in pediatric patients. Pediatrics 2007; 120:e713-722.
24. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116:7-15.
25. Saule C, Boccon-Gibod I, Fain O etal. Benefits of progestin contraception in non-allergic angioedema. Clin Exp Allergy 2013; 43:475-482.